肝脏吻合状血管瘤:病例系列
本文回顾性分析2004年6月至2018年3月本机构数据库中5例经病理证实的肝脏吻合状血管瘤,复习其CT、超声和MRI表现及临床病理资料。影像学特征多变,但弥散加权成像周边或弥漫高信号、动脉期高强化且无结节状中断强化、延迟期持续强化且无完全填充较具特征性,且缺乏侵袭性征象。AHL在影像和病理上可模仿血管肉瘤等恶性病变,确诊后首选监测,干预可致不必要的并发症,迄今未发现恶变。
要点
- AHL影像表现多变,弥散加权成像周边或弥漫高信号、动脉期高强化无结节状中断强化、延迟期持续强化无完全填充较具特征性。
- AHL在影像和病理上可模仿血管肉瘤等恶性病变,诊断存在困难。
- 确诊AHL后首选监测,干预可致不必要的并发症,迄今未发现恶变。
核心结论
- AHL在影像和病理上可模仿血管肉瘤等恶性病变,诊断存在困难;影像特征虽多变,但部分特征有助于与其他肝脏病变鉴别;确诊后首选监测,干预可致不必要的并发症,迄今未发现恶变。
研究设计与样本
- 回顾性研究,利用本机构数据库自2004年6月至2018年3月检索经病理证实的肝脏吻合状血管瘤,纳入有影像可供复习者,共5例;复习CT、超声和MRI表现(部位、大小、密度/信号强度、强化特征及其他影像数据)及临床病理资料。
关键影像表现/征象
- 弥散加权成像上呈周边或弥漫高信号。
- 动脉期高强化,无结节状中断强化。
- 延迟期持续强化,无完全填充。
- 影像上缺乏侵袭性征象。
- 影像特征总体表现多变。
临床应用与阅片要点
- 作者指出,当已知吻合状血管瘤诊断时,首选处理为监测,因干预可致不必要的并发症,迄今未发现恶变。
- 作者指出AHL在影像上可模仿血管肉瘤等恶性病变,诊断存在困难。
- 作者指出AHL影像特征多变,但部分特征可帮助与其他肝脏病变鉴别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To report imaging and pathologic features of five pathologically proven anastomosing hemangiomas of the liver (AHL).
METHODS: A retrospective review for AHL was conducted using our institutional database from 6/2004 to 3/2018. Histology proven AHL with radiologic imaging available for review were included. A total of five patients who met our criteria were identified from our institutional database. Computed tomography, ultrasound, and magnetic resonance imaging findings, including location, size, attenuation/signal intensity, enhancement characteristics, and additional imaging data were reviewed. The clinical and pathological data were also reviewed.
RESULTS: The imaging characteristics of AHL are variable, but features such as peripheral or diffuse hyperintensity on diffusion weighted imaging, arterial hyperenhancement without globular interrupted enhancement, and persistent enhancement without complete filling in the delayed phases were more characteristic of AHL. Imaging also demonstrated a lack of aggressive features.
CONCLUSIONS: AHL present a diagnostic dilemma as they can mimic more malignant lesions, such as angiosarcoma, both on imaging and at pathology. While the imaging characteristics of AHL are variable, there are some features which can help distinguish AHL from other liver lesions. When the diagnosis of anastomosing hemangioma is known, the management of choice is primarily surveillance, as intervention can cause unnecessary morbidity, and no degeneration to malignancy has been identified to date.
引用
- Lunn B, Yasir S, Lam-Himlin D, et al. Anastomosing hemangioma of the liver: a case series. Abdom Radiol (NY). 2019. PMID: 31069477. doi:10.1007/s00261-019-02043-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。